News und Analysen
Kailas FUGA setzt neue Maßstäbe im Trailrunning mit dem FUGA EX PRO G
Die Wahl der Elite für Europas größte Trailrennen 2026
Athlet testet den FUGA EX PRO G Bildnachweis: Kailas FUGA
GUANGZHOU, China, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Kailas FUGA bringt mit dem
Home Depot Analysts See a Path to $375 and Beyond
Key Points
- Interested in The Home Depot, Inc.? Here are five stocks we like better.
- Home Depot posted a stronger-than-expected Q2, with revenue up 5.7% to $47.9 billion and adjusted EPS of $4.92
Tenaya Therapeutics Eyes Q4 Updates for Cardiac Gene Therapies, TN-301
Key Points
- Interested in Tenaya Therapeutics, Inc.? Here are five stocks we like better.
- Tenaya expects fourth-quarter updates on its TN-201 and TN-401 cardiac gene therapy programs, including
Sagimet Biosciences Eyes U.S. Phase III Acne Study After Positive China Data
Key Points
- Interested in Sagimet Biosciences Inc.? Here are five stocks we like better.
- Positive China data: Ascletis’ Phase III trial of denifanstat in 480 patients with moderate-to-severe acne
Repay Eyes Faster Growth, Debt Reduction as KUBRA Builds Consumer Billing Platform
Key Points
- Interested in Repay Holdings Corporation? Here are five stocks we like better.
- Repay is broadening its consumer billing platform through the KUBRA acquisition, combining payment
Avita Medical Targets Q4 2025 Cash Flow Breakeven as Revenue Growth Builds
Key Points
- Interested in Avita Medical Inc.? Here are five stocks we like better.
- Avita Medical raised its 2025 revenue guidance to $86 million–$89 million, citing sequential growth from $17.6
Quanterix Reshapes Sales Strategy, Targets Q4 FDA Decision for Alzheimer’s Blood Test
Key Points
- Interested in Quanterix Corporation? Here are five stocks we like better.
- Quanterix is restructuring its sales organization into dedicated teams for spatial biology, Simoa products
Pagaya Targets $200M Net Income Run Rate as Lending Network Expands
Key Points
- Interested in Pagaya Technologies Ltd.? Here are five stocks we like better.
- Pagaya expects to exit the year with a $200 million GAAP net income run rate after reporting $45 million
Energy Fuels Aktie: BMO stuft auf Strong-Buy hoch
Am heutigen Samstag sorgt eine deutliche Neueinstufung für Aufsehen im Uransektor. Die Experten von…
Der Beitrag Energy Fuels Aktie: BMO stuft auf Strong-Buy hoch erschien zuerst auf kapitalmarktexp
908 Devices Eyes Growth in Handheld Drug and Chemical Detection Market
Key Points
- Interested in 908 Devices Inc.? Here are five stocks we like better.
- 908 Devices is refocusing on handheld chemical and drug detection after divesting its bioprocessing and
Pulmonx Rebuilds Sales Force, Targets Growth and AeriSeal Launch Next Year
Key Points
- Interested in Pulmonx Corporation? Here are five stocks we like better.
- Pulmonx is rebuilding its sales organization after elevated turnover in 2025, with leadership positions
Kiniksa Highlights ARCALYST Growth as KPL-387 Advances Into Phase 3
Key Points
- Interested in Kiniksa Pharmaceuticals International, plc? Here are five stocks we like better.
- ARCALYST revenue growth accelerated: Kiniksa reported approximately $243 million in
Kaltura Bets on Agentic AI to Drive Next-Gen Video Growth
Key Points
- Interested in Kaltura, Inc.? Here are five stocks we like better.
- Kaltura is expanding into agentic AI, combining its video infrastructure with conversational AI, avatars
ICF International Eyes Growth Rebound as Energy, AI and Federal Modernization Gain Traction
Key Points
- Interested in ICF International, Inc.? Here are five stocks we like better.
- ICF expects a growth rebound: After a roughly 25% decline in federal business in 2025, the company projects
Cybin Conference: Helus CEO Eyes Q4 Phase III Depression Data for HLP003
Key Points
- Interested in Cybin Inc.? Here are five stocks we like better.
- Helus expects fourth-quarter top-line results from the first Phase III trial of HLP003, an adjunctive treatment for
Canadian Tire Q2 Earnings Call Highlights
Key Points
- Interested in Canadian Tire Co., Limited? Here are five stocks we like better.
- Q2 earnings increased: Normalized diluted EPS rose 10% to C$3.94, supported by stronger performance at
EZCORP Eyes Faster Expansion After Record Quarter, SMG Deal
Key Points
- Interested in EZCORP, Inc.? Here are five stocks we like better.
- Record quarterly performance drove EZCORP’s growth, with adjusted EBITDA up 48% and adjusted EPS up 47%. The company
Entera Bio Eyes Phase 3 Start for Oral Osteoporosis Drug EB613 After FDA Agreement
Key Points
- Interested in Entera Bio Ltd.? Here are five stocks we like better.
- Entera Bio plans to launch a Phase 3 trial of oral osteoporosis candidate EB613 after reaching agreement with the
EQS-News: ProCredit mit erfolgreicher Strategieumsetzung in H1 2026: Starkes und zielgerichtetes Kreditwachstum bei gesteigerter Nettozinsmarge
EQS-News: ProCredit mit erfolgreicher Strategieumsetzung in H1 2026: Starkes und zielgerichtetes Kreditwachstum bei gesteigerter Nettozinsmarge
Biodesix Sees Nodify Growth, Reaffirms Revenue Outlook at Canaccord Conference
Key Points
- Interested in Biodesix, Inc.? Here are five stocks we like better.
- Biodesix reaffirmed full-year revenue guidance of $108 million to $114 million, representing roughly 25%
Constellation Software Q2 Earnings Call Highlights
Key Points
- Interested in Constellation Software Inc.? Here are five stocks we like better.
- AI strategy remains decentralized: Constellation is using AI mainly to improve development
BTB Real Estate Investment Trust Q2 Earnings Call Highlights
Key Points
- Interested in BTB Real Estate Investment Trust? Here are five stocks we like better.
- BTB is shifting toward industrial real estate: Industrial assets now represent 38% of the
DroneShield Aktie: 206 Millionen Austral-Dollar bestätigt
DroneShield hat auf der Canaccord Genuity Growth Conference am Mittwoch vergangener Woche einen Ausblick…
Der Beitrag DroneShield Aktie: 206 Millionen Austral-Dollar bestätigt erschien zuerst auf ka
CeriBell Expands EEG Platform Beyond Seizures With Delirium, Pediatric Push
Key Points
- Interested in CeriBell, Inc.? Here are five stocks we like better.
- CeriBell is expanding beyond seizure detection into neonatal, pediatric and delirium monitoring, raising its
EQS-News: Medios setzt Wachstumskurs im 1. Halbjahr 2026 fort und richtet Fokus auf Profitabilität und Cash Conversion
EQS-News: Medios setzt Wachstumskurs im 1. Halbjahr 2026 fort und richtet Fokus auf Profitabilität und Cash Conversion